KDRA to withdraw discontinuation of government's R&D new drug assistance program

The Korea Drug Research Association presented to the Ministry of Health and Welfare a written petition related to the outstanding five industry recommendations on March 12, requesting that the ministry withdraw its policy to discontinue a new R&D funding program to domestic pharmaceutical industry. The five recommendations from the industry cover:

1) Supplemental compilation of 2003 R&D budg...